← Back to patent-cliff list
CAS 109371-19-9
4-methoxy-2,3,5-trimethylpyridine
Codes: OMEP-009
Application context (from source-drug indications)
Helicobacter pylori infectionAmoxicillin/Omeprazole/RifabutinDyspepsiaAmoxicillin/Omeprazole/RifabutinGastric ulcerCinitapride Tartrate/OmeprazoleGastro-oesophageal reflux diseaseCinitapride Tartrate/OmeprazoleDyspepsiaCinitapride Tartrate/OmeprazoleHeartburnOmeprazoleGastro-oesophageal reflux diseaseOmeprazoleGastric ulcerOmeprazoleHyperacidityOmeprazoleDuodenal ulcerOmeprazoleHelicobacter pylori infectionOmeprazole
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Amoxicillin/Omeprazole/Rifabutin | Tier C — Watch / trade | - |
| Cinitapride Tartrate/Omeprazole | Tier C — Watch / trade | - |
| Omeprazole | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
5-methoxy-1H-benzo[d]imidazole-2-thiol→sodium 5-methoxy-2-sulfinatobenzo[d]imidazol-1-ide→OMEP-008→4-methoxy-2,3,5-trimethylpyridine
5-methoxy-1H-benzo[d]imidazole-2-thiol→sodium 5-methoxy-2-sulfinatobenzo[d]imidazol-1-ide→OMEP-008→4-methoxy-2,3,5-trimethylpyridine
5-methoxy-1H-benzo[d]imidazole-2-thiol→sodium 5-methoxy-2-sulfinatobenzo[d]imidazol-1-ide→OMEP-008→4-methoxy-2,3,5-trimethylpyridine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.